Subanesthetic isoflurane reduces zymosan-induced inflammation in murine Kupffer cells by inhibiting ros-activated p38 MAPK/NF - κ b signaling

Oxidative Medicine and Cellular Longevity

Volumn 2014, Issue , 2014, Pages

  Wang, Hui ^a   Wang, Lei ^a   Li, Nan Lin ^a   Li, Jun Tang ^b,c   Yu, Feng ^b   Zhao, Ya Li ^b   Wang, Ling ^a,b   Yi, Jun ^a   Bian, Jie Fang ^a   Chen, Jiang Hao ^a   Yuan, Shi Fang ^a   Wang, Ting ^a   Lv, Yong Gang ^a   Liu, Ning Ning ^b   Zhu, Xiao Shan ^b   Ling, Rui ^a   Yun, Jun ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b Institute of Anal Colorectal Surgery   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETICS; BIOASSAY; CHEMICAL ACTIVATION; ENZYME ACTIVITY; ENZYMES; LIVER; MACROPHAGES; PATHOLOGY; PROTEINS;

ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOMODULATORY EFFECTS; INFLAMMATORY RESPONSE; MACROPHAGE INFLAMMATORY PROTEINS; NUCLEAR TRANSLOCATIONS; P38 MITOGEN-ACTIVATED PROTEIN KINASE; REACTIVE OXYGEN SPECIES; TUMOR NECROSIS FACTORS;

CELL SIGNALING;

CYCLOOXYGENASE 2; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; ISOFLURANE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 2; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; PROSTAGLANDIN E2; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; ZYMOSAN; ANESTHETIC AGENT; CHEMOKINE; CYTOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME LINKED IMMUNOSPOT ASSAY; IN VIVO STUDY; INFLAMMATION; KUPFFER CELL; LIVER; MACROPHAGE; MALE; MOUSE; NONHUMAN; PROSTAGLANDIN RELEASE; RADIOIMMUNOASSAY; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; DRUG-INDUCED LIVER INJURY; METABOLISM; PATHOLOGY;

ANESTHETICS; ANIMALS; CELLS, CULTURED; CHEMOKINES; CYCLOOXYGENASE 2; CYTOKINES; DRUG-INDUCED LIVER INJURY; INFLAMMATION; ISOFLURANE; KUPFFER CELLS; LIVER; MALE; MICE; MICE, INBRED BALB C; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; ZYMOSAN;

EID: 84924239339     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2014/851692     Document Type: Article

References (50)

1. G. S. Martin, D. M. Mannino, S. Eaton, and M. Moss, "The epidemiology of sepsis in the United States from 1979 through 2000, " The New England Journal of Medicine, vol. 348, no. 16, pp. 1546-1554, 2003.
2. C. Alberti, C. Brun-Buisson, H. Burchardi et al., "Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study, " Intensive Care Medicine, vol. 28, no. 2, pp. 108-121, 2002.
3. R. J. A. Goris, W. K. F. Boekholtz, I. P. T. van Bebber, J. K. Nuytinck, and P. H. Schillings, "Multiple-organ failure and sepsis without bacteria: an experimental model, " Archives of Surgery, vol. 121, no. 8, pp. 897-901, 1986.
4. R. di Paola, E. Mazzon, T. Genovese et al., "Ethyl pyruvate reduces the development of zymosan-induced generalized inflammation in mice, " Critical Care Medicine, vol. 37, no. 1, pp. 270-282, 2009.
5. J. Mu, K. Xie, L. Hou et al., "Subanesthetic dose of isoflurane protects against zymosan-induced generalized inflammation and its associated acute lung injury in mice, " Shock, vol. 34, no. 2, pp. 183-189, 2010.
6. J. T. Li, H. Wang, W. Li et al., "Anesthetic isoflurane posttreatment attenuates experimental lung injury by inhibiting inflammation and apoptosis, " Mediators of Inflammation, vol. 2013, Article ID108928, 16 pages, 2013.
7. H. Wang, J. Fan, N. L. Li et al., "A subanesthetic dose of isoflurane during postconditioning ameliorates zymosan-induced neutrophil inflammation lung injury and mortality in mice," Mediators of Inflammation, vol. 2013, Article ID 479628, 14 pages, 2013.
8. A. Ozinsky, D. M. Underhill, J. D. Fontenot et al., "The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors," Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 25, pp. 13766-13771, 2000.
9. Y. Ikeda, Y. Adachi, T. Ishii, N. Miura, H. Tamura, and N. Ohno, "Dissociation of toll-like receptor 2-mediated innate immune response to zymosan by organic solvent-treatment without loss of dectin-1 reactivity, " Biological and Pharmaceutical Bulletin, vol. 31, no. 1, pp. 13-18, 2008.
10. R. Di Paola, M. Galuppo, E. Mazzon, I. Paterniti, P. Bramanti, and S. Cuzzocrea, "PD98059, a specific MAP kinase inhibitor, attenuates multiple organ dysfunction syndrome/failure (MODS) induced by zymosan in mice, " Pharmacological Research, vol. 61, no. 2, pp. 175-187, 2010.
11. S. I. Jang, H. J. Kim, Y. J. Kim, S. I. Jeong, and Y. O. You, "Tanshinone IIA inhibits LPS-induced NF-κB activation in RAW 264. 7 cells: possible involvement of the NIK-IKK, ERK1/2, p38 and JNKpathways, " European Journal of Pharmacology, vol. 542, no. 1-3, pp. 1-7, 2006.
12. K. Asehnoune, D. Strassheim, S. Mitra, J. Y. Kim, and E. Abraham, "Involvement of reactive oxygen species in Toll-like receptor 4-dependent activation of NF-κB, " Journal of Immunology, vol. 172, no. 4, pp. 2522-2529, 2004.
13. S. Karunakaran and V. Ravindranath, "Activation of p38MAPK in the substantia nigra leads to nuclear translocation of NF-κB in MPTP-treated mice: implication in Parkinsons disease," Journal of Neurochemistry, vol. 109, no. 6, pp. 1791-1799, 2009.
14. Y. Xiang, X. Chen, J. Li et al., "Isoflurane regulates atypical typea γ-aminobutyric acid receptors in alveolar type II epithelial cells, " Anesthesiology, vol. 118, no. 5, pp. 1065-1075, 2013.
15. J. Fan, R. D. Ye, and A. B. Malik, "Transcriptional mechanisms of acute lung injury, " American Journal of Physiology-Lung Cellular and Molecular Physiology, vol. 281, no. 5, pp. L1037-L1050, 2001.
16. G. D. Brown, J. Herre, D. L. Williams, J. A. Willment, A. S. J. Marshall, and S. Gordon, "Dectin-1 mediates the biological effects of β-glucans, " Journal of ExperimentalMedicine, vol. 197, no. 9, pp. 1119-1124, 2003.
17. R. G. Allen and M. Tresini, "Oxidative stress and gene regulation," Free Radical Biology andMedicine, vol. 28, no. 3, pp. 463-499, 2000.
18. B. N. Gantner, R. M. Simmons, S. J. Canavera, S. Akira, and D. M. Underhill, "Collaborative induction of inflammatory responses by dectin-1 and toll-like receptor 2, " Journal of Experimental Medicine, vol. 197, no. 9, pp. 1107-1117, 2003.
19. G. J. Crystal, G. Malik, S.-H. Yoon, and S.-J. Kim, "Isoflurane late preconditioning against myocardial stunning is associated with enhanced antioxidant defenses, " Acta Anaesthesiologica Scandinavica, vol. 56, no. 1, pp. 39-47, 2012.
20. C. Hofstetter, K. A. Boost, S. Hoeg et al., "Norepinephrine and vasopressin counteract anti-inflammatory effects of isoflurane in endotoxemic rats, " International Journal of Molecular Medicine, vol. 20, no. 4, pp. 597-604, 2007.
21. S. J. Si, F. T. Fi, and C. A. Ti, "Cardiac anesthesia, " in Cardiac Surgery in the Adult, L. H. Cohn and L. H. Edmunds Jr. , Eds. , pp. 249-281, McGraw-Hill, NewYork, NY, USA, 2003.
22. P. V. Sackey, C. Martling, C. Carlswärd, Ö. Sundin, and P. J. Radell, "Short-and long-term follow-up of intensive care unit patients after sedation with isoflurane and midazolam-a pilot study, " Critical Care Medicine, vol. 36, no. 3, pp. 801-806, 2008.
23. V. Shankar, K. B. Churchwell, and J. K. Deshpande, "Isoflurane therapy for severe refractory status asthmaticus in children," Intensive Care Medicine, vol. 32, no. 6, pp. 927-933, 2006.
24. W. Q. Zeng, J. Q. Zhang, Y. Li, K. Yang, Y. P. Chen, and Z. J. Liu, "Anewmethod to isolate and culture rat kupffer cells, " PLoS ONE, vol. 8, no. 8, Article ID e70832, 2013.
25. Y. Kawaraguchi, Y. T. Horikawa, A. N. Murphy et al., "Volatile anesthetics protect cancer cells against tumor necrosis factorrelated apoptosis-inducing ligand-induced apoptosis via caveolins," Anesthesiology, vol. 115, no. 3, pp. 499-508, 2011.
26. T.-N. Lin, Y. Y. He, G. Wu, M. Khan, C. Y. Hsu, and A. Marmarou, "Effect of brain edema on infarct volume in a focal cerebral ischemia model in rats, " Stroke, vol. 24, no. 1, pp. 117-121, 1993.
27. P. N. Olson, R. A. Bowen, M. D. Behrendt, J. D. Olson, and T. M. Nett, "Validation of radioimmunoassays to measure prostaglandins F(2α) and E2 in canine endometrium and plasma, " The American Journal of Veterinary Research, vol. 45, no. 1, pp. 119-124, 1984.
28. R. Ye, X. Kong, Q. Yang, Y. Zhang, J. Han, and G. Zhao, "Ginsenoside Rd attenuates redox imbalance and improves stroke outcome after focal cerebral ischemia in aged mice, " Neuropharmacology, vol. 61, no. 4, pp. 815-824, 2011.
29. K. R. Dave, R. A. DeFazio, A. P. Raval et al., "Ischemic preconditioning targets the respiration of synaptic mitochondria via protein kinase C, " Journal of Neuroscience, vol. 28, no. 16, pp. 4172-4182, 2008.
30. S. Krahenbuhl, M. Chang, E. P. Brass, and C. L. Hoppel, "Decreased activities of ubiquinol :ferricytochrome c oxidoreductase (complex III) and ferrocytochrome c:oxygen oxidoreductase (complex IV) in liver mitochondria from rats with hydroxycobalamin [c-lactam]-induced methylmalonic aciduria, "The Journal of Biological Chemistry, vol. 266, no. 31, pp. 20998-21003, 1991.
31. S. Suram, G. D. Brown, M. Ghosh et al., "Regulation of cytosolic phospholipase A2 activation and cyclooxygenase 2 expression in macrophages by the β-glucan receptor, " The Journal of Biological Chemistry, vol. 281, no. 9, pp. 5506-5514, 2006.
32. S. Pestel, G. Schlaf, O. Götze, K. Jungermann, and H. L. Schieferdecker, "Differences in the involvement of prostanoids from Kupffer cells in the mediation of anaphylatoxin C5a-, zymosan-, and lipopolysaccharide-dependent hepatic glucose output and flow reduction, " Laboratory Investigation, vol. 83, no. 12, pp. 1733-1741, 2003.
33. F. Moriconi, G. Ahmad, P. Ramadori et al., "Phagocytosis of gadolinium chloride or zymosan induces simultaneous upregulation of hepcidin-and downregulation of hemojuvelin-and Fpn-1-gene expression in murine liver, " Laboratory Investigation, vol. 89, no. 11, pp. 1252-1260, 2009.
34. J. Henao-Mejia, E. Elinav, C. A. Thaiss, P. Licona-Limon, and R. A. Flavell, "Role of the intestinal microbiome in liver disease," Journol of Autoimmunology, vol. 46, pp. 66-73, 2013.
35. G. Kolios, V. Valatas, and E. Kouroumalis, "Role of Kupffer cells in the pathogenesis of liver disease, " World Journal of Gastroenterology, vol. 12, no. 46, pp. 7413-7420, 2006.
36. T. S. Blackwell, T. R. Blackwell, and J. W. Christman, "Impaired activation of nuclear factor-kappaB in endotoxin-tolerant rats is associated with down-regulation of chemokine gene expression and inhibition of neutrophilic lung inflammation," Journal of Immunology, vol. 158, no. 12, pp. 5934-5940, 1997.
37. C. A. Gogos, E. Drosou, H. P. Bassaris, and A. Skoutelis, "Pro-versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options, " Journal of Infectious Diseases, vol. 181, no. 1, pp. 176-180, 2000.
38. M. Kinoshita, T. Uchida, A. Sato et al., "Characterization of two F4/80-positiveKupffer cell subsets by their function and phenotype in mice, " Journal of Hepatology, vol. 53, no. 5, pp. 903-910, 2010.
39. X. Wu, Y. Lu, Y. Dong et al., "The inhalation anesthetic isoflurane increases levels of proinflammatory TNF-α, IL-6, and IL-1β, " Neurobiology of Aging, vol. 33, no. 7, pp. 1364-1378, 2012.
40. N. Kotani, S. Takahashi, D. I. Sessler et al., "Volatile anesthetics augment expression of proinflammatory cytokines in rat alveolar macrophages during mechanical ventilation, " Anesthesiology, vol. 91, no. 1, pp. 187-197, 1999.
41. Z. Q. Li, X. Y. Rong, Y. J. Liu et al., "Activation of the canonical nuclear factor-κB pathway is involved in isoflurane-induced hippocampal interleukin-1β elevation and the resultant cognitive deficits in aged rats, " Biochemical and Biophysical Research Communications, vol. 438, no. 4, pp. 628-634, 2013.
42. M. Flondor, C. Hofstetter, K. A. Boost, C. Betz, M. Homann, and B. Zwissler, "Isoflurane inhalation after induction of endotoxemia in rats attenuates the systemic cytokine response," European Surgical Research, vol. 40, no. 1, pp. 1-6, 2008.
43. Q. F. Li, Y. S. Zhu, H. Jiang, H. Xu, and Y. Sun, "Isoflurane preconditioning ameliorates endotoxin-induced acute lung injury andmortality in rats, " Anesthesia & Analgesia, vol. 109, no. 5, pp. 1591-1597, 2009.
44. H. T. Lee, M. Kim, N. Kim, F. T. Billings IV, V. D. Dagati, and C. W. Emala Sr. , "Isoflurane protects against renal ischemia and reperfusion injury and modulates leukocyte infiltration in mice, " American Journal of Physiology: Renal Physiology, vol. 293, no. 3, pp. F713-F722, 2007.
45. M. Kim, S. W. Park, V. D. DAgati, and H. T. Lee, "Isoflurane activates intestinal sphingosine kinase to protect against renal ischemia-reperfusion-induced liver and intestine injury, " Anesthesiology, vol. 114, no. 2, pp. 363-373, 2011.
46. C. A. Picq, D. Clarencon, V. E. Sinniger, B. L. Bonaz, and J. S. Mayol, "Impact of anesthetics on immune functions in a rat model of vagus nerve stimulation, " PLoS ONE, vol. 8, no. 6, Article ID e67086, 2013.
47. M. M. Saad, W. Eom, G. Hu, S. J. Kim, and G. J. Crystal, "Persistency and pathway of isoflurane-induced inhibition of superoxide production by neutrophils, " Canadian Journal of Anesthesia, vol. 57, no. 1, pp. 50-57, 2010.
48. E. Wypasek, J. Natorska, A. I. Mazur, and E. Kolaczkowska, "Toll-like receptors expression and NF-κB activation in peritoneal leukocytes in morphine-mediated impairment of zymosan-induced peritonitis in Swiss mice, " Archivum Immunologiae et Therapiae Experimentalis, vol. 60, no. 5, pp. 373-382, 2012.
49. H. Choi, R. H. Lee, N. Bazhanov, J. Y. Oh, and D. J. Prockop, "Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2/NF-κB signaling in resident macrophages, " Blood, vol. 118, no. 2, pp. 330-338, 2011.
50. E. LHer, L. Dy, R. Pili et al., "Feasibility and potential cost/ benefit of routine isoflurane sedation using an anestheticconserving device: a prospective observational study, " Respiratory Care, vol. 53, no. 10, pp. 1295-1303, 2008.